Author pages are created from data sourced from our academic publisher partnerships and public sources.
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification… Expand
The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated NETs of the Distal Colon and Rectum
Neuroendocrine tumors (NETs) of the distal colon and rectum are also known as hindgut carcinoids based on their common embryologic derivation. Their annual incidence in the United States is rising,… Expand
An eleven-year experience with adrenocortical carcinoma.
BACKGROUND Key issues in the treatment of adrenocortical carcinoma are the value of adjuvant therapy, the value of reoperation, and the search for effective chemotherapeutic agents. The present… Expand
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
Abstract There have been significant developments in diagnostic and therapeutic options for patients with neuroendocrine tumors (NETs). Key phase 3 studies include the CLARINET trial, which evaluated… Expand
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study.
- J. Yao, M. Pavel, +11 authors K. Öberg
- Journal of clinical oncology : official journal…
- 30 September 2016
Purpose Everolimus improved median progression-free survival by 6.4 months in patients with advanced pancreatic neuroendocrine tumors (NET) compared with placebo in the RADIANT-3 study. Here, we… Expand
Synchronous colon primaries have the same prognosis as solitary colon cancers
PURPOSE: This study was designed to determine the prognosis of patients with synchronous colon primary tumors. METHODS: An 18-year, multi-institutional database of 4,878 colon cancer patients was… Expand
Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.
- J. Vetto, R. Pommier, W. Schmidt, H. Eppich, P. W. Alexander
- Archives of surgery
- 1 September 1996
OBJECTIVE To study the accuracy and cost of diagnosing palpable breast lesions in younger patients using a modified triple test (MTT: physical examination, ultrasonography instead of mammography, and… Expand
The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society
Abstract Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the past decades, and are now the most common type of small bowel tumor. Consequently, general surgeons and… Expand
Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
- M. Kulke, J. Bendell, L. Kvols, J. Picus, R. Pommier, J. Yao
- Journal of hematology & oncology
- 14 June 2011
Pancreatic neuroendocrine tumors (NET) have diverse clinical presentations. Patients with symptoms of hormone secretion may require specific medical interventions to control those symptoms prior to… Expand
Usefulness of the triple test score for palpable breast masses; discussion 1012-3.
HYPOTHESIS The triple test score (TTS) is useful and accurate for evaluating palpable breast masses. DESIGN Diagnostic test study. SETTING University hospital multidisciplinary breast clinic. … Expand